These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

29 related articles for article (PubMed ID: 31976676)

  • 1. Desulfonylative Functionalization of Organosulfones via Inert (Hetero)Aryl C(
    Huang R; Gu B; Wang M; Zhao Y; Jiang X
    Molecules; 2024 Aug; 29(17):. PubMed ID: 39274985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in synthesis and application of furoxan.
    Abu Yousef M; Matsubara R
    RSC Adv; 2023 Feb; 13(8):5228-5248. PubMed ID: 36777951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent Advances in the Synthesis and Biomedical Applications of Heterocyclic NO-Donors.
    Fershtat LL; Zhilin ES
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of alkynyl furoxans. Rare carbon-carbon bond-forming reaction on a furoxan ring.
    Matsubara R; Eguchi S; Ando A; Hayashi M
    Org Biomol Chem; 2017 Mar; 15(9):1965-1969. PubMed ID: 28181597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tert-Butyl Nitrite-initiated C-N Bond Cleavage of 1-Nitromethyl-N-aryltetrahydroisoquinolines: Synthesis of Furoxans with N-NO Skeleton.
    Sun Z; Zhang S; Ma Q; Li Y; Ding H; Yuan Y; Jia X
    Chem Asian J; 2023 Mar; 18(5):e202201265. PubMed ID: 36655414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Synthetic Application of Chloro- and Bromofuroxans.
    Matsubara R; Ando A; Hasebe H; Kim H; Tsuneda T; Hayashi M
    J Org Chem; 2020 May; 85(9):5959-5972. PubMed ID: 32242666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regioselective Synthesis of NO-Donor (4-Nitro-1,2,3-triazolyl)furoxans via Eliminative Azide-Olefin Cycloaddition.
    Stebletsova IA; Larin AA; Ananyev IV; Fershtat LL
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of furoxans as a new class of tolerance-resistant nitrovasodilators.
    Hecker M; Vorhoff W; Bara AT; Mordvintcev PI; Busse R
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr; 351(4):426-32. PubMed ID: 7630432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modular Synthesis of Carbon-Substituted Furoxans via Radical Addition Pathway. Useful Tool for Transformation of Aliphatic Carboxylic Acids Based on "Build-and-Scrap" Strategy.
    Matsubara R; Kim H; Sakaguchi T; Xie W; Zhao X; Nagoshi Y; Wang C; Tateiwa M; Ando A; Hayashi M; Yamanaka M; Tsuneda T
    Org Lett; 2020 Feb; 22(3):1182-1187. PubMed ID: 31976676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic Strategies Toward Nitrogen-Rich Energetic Compounds
    Wang L; Zhai L; She W; Wang M; Zhang J; Wang B
    Front Chem; 2022; 10():871684. PubMed ID: 35372281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of furoxans and benzofuroxans: recent developments.
    Cerecetto H; Porcal W
    Mini Rev Med Chem; 2005 Jan; 5(1):57-71. PubMed ID: 15638792
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.